Authors:
Freifeld, A
Marchigiani, D
Walsh, T
Chanock, S
Lewis, L
Hiemenz, J
Hiemenz, S
Hicks, JE
Gill, V
Steinberg, SM
Pizzo, PP
Citation: A. Freifeld et al., A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy, N ENG J MED, 341(5), 1999, pp. 305-311
Authors:
Lee, KH
Wang, E
Nielsen, MB
Wunderlich, J
Migueles, S
Connors, M
Steinberg, SM
Rosenberg, SA
Marincola, FM
Citation: Kh. Lee et al., Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but doesnot lead to tumor regression, J IMMUNOL, 163(11), 1999, pp. 6292-6300
Authors:
Chougnet, C
Fowke, KR
Mueller, BU
Smith, S
Zuckerman, J
Jankelevitch, S
Steinberg, SM
Luban, N
Pizzo, PA
Shearer, GM
Citation: C. Chougnet et al., Protease inhibitor and triple-drug therapy: cellular immune parameters arenot restored in pediatric AIDS patients after 6 months of treatment, AIDS, 12(18), 1998, pp. 2397-2406
Authors:
Bauer, KS
Kohn, EC
Lush, RM
Steinberg, SM
Davis, P
Kohler, D
Reed, E
Figg, WD
Citation: Ks. Bauer et al., Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: Use of a single model for simultaneous determination of changing parameters, J PHAR BIOP, 26(6), 1998, pp. 673-687
Authors:
Foster, CB
Lehrnbecher, T
Mol, F
Steinberg, SM
Venzon, DJ
Walsh, TJ
Noack, D
Rae, J
Winkelstein, JA
Curnutte, JT
Chanock, SJ
Citation: Cb. Foster et al., Host defense molecule polymorphisms influence the risk for immune-mediatedcomplications in chronic granulomatous disease, J CLIN INV, 102(12), 1998, pp. 2146-2155
Authors:
Jarrard, JA
Linnoila, RI
Lee, HR
Steinberg, SM
Witschi, H
Szabo, E
Citation: Ja. Jarrard et al., MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis, CANCER RES, 58(23), 1998, pp. 5582-5589